What’s coming for cancer in the 2020s 23 Jan 2020 We’ve learned a lot about cancer in the last decade, with survival rates better now than ever before. Our Policy Adviser, Roya Ziaie, takes a look at what might be in store over the next ten years in an ever-changing field. Find out more Show/Hide
Making the case for ‘regulatory innovation’ in cancer research 02 Dec 2019 Regulation of new cancer therapies, whilst crucially important, can become a barrier to innovation. Our Policy Adviser, Roya Ziaie, takes a look at the current regulatory landscape and what is needed in the future to ensure innovative treatments find their way to patients as quickly as possible. Find out more Show/Hide
The 100,000 Genomes Project has finished: what were the challenges and what comes next? 07 Dec 2018 This week, the Health Secretary Matt Hancock announced that the 100,000 Genomes Project has reached its goal of decoding 100,000 genomes from NHS patients. We take a look at some of the challenges that had to be overcome to reach this point and ask what happens next? Find out more Show/Hide
Investing in the future – what does the life sciences sector deal mean for cancer research? 08 Dec 2017
Science after Brexit – how will we continue to collaborate with the EU on medical research? 08 Sep 2017